A founder once asked an investor how she came up with his number. She smiled and said, “Partly math, partly mood.” That answer is closer to the truth than most pitch decks admit, and it explains why startup valuation confuses so many first-time founders.
The good news is that the math has a structure. Once you understand the common methods and the benchmarks behind them, you can walk into a room with a defensible figure instead of a hopeful guess.
Why Pre-Revenue Startup Valuation Is So Hard
A mature company has earnings, customers, and a track record. You can value it by looking at what it makes and what similar companies sold for.
A pre-revenue startup has almost none of that. There are no profits to discount and often no sales to multiply, so any startup valuation at this stage rests on potential rather than performance.
That is why early numbers swing so widely. Two investors can look at the same team and arrive at figures that differ by millions, because they are pricing risk and belief, not results.
For a focused walkthrough, see our guide on how to value a pre-revenue startup.
The Berkus Method
The Berkus Method comes from angel investor Dave Berkus, and it sidesteps financial projections entirely. Instead of forecasting revenue, it scores how much risk the startup has already removed.
It assigns up to $500,000 of value to each of five factors: a sound idea, a working prototype, a quality management team, strategic relationships, and early product rollout or sales. Adding the five together caps a pre-revenue valuation at roughly $2.5 million.
The appeal is simplicity. The limit is that it works best for early, US-style angel deals and tends to break down once real traction or larger markets enter the picture.
The Scorecard (Bill Payne) Method
The Scorecard Method, also called the Bill Payne method, values your startup by comparison. It starts with the average pre-money valuation for recent deals in your region, industry, and stage.
From there, it adjusts up or down based on weighted factors such as the strength of the team, the size of the opportunity, the product, the competitive position, and the need for more funding. A stronger-than-average team might push your number above the regional baseline, while a crowded market might pull it down.
This method can feel more grounded than a flat formula because it ties your value to what comparable startups actually command. Its weakness is that it depends on having reliable local benchmark data.
The VC Method and Comparables
The VC Method works backward from an exit. An investor estimates what the company might sell for in five to seven years, then divides by the return they need to justify the risk.
For example, an investor expecting a 10x return on a startup they believe could exit at $100 million would back into a post-money value near $10 million today. They then subtract their investment to reach the pre-money figure.
Comparables, or market multiples, take a similar outside-in view. You look at what similar companies were valued at relative to their revenue or users, then apply that ratio to your own numbers.
Where DCF and Cost-to-Duplicate Fit
Discounted cash flow, or DCF, values a company based on its projected future cash, adjusted for risk and time. It is a serious tool for profitable businesses.
For startups it is usually weak. The forecasts reach so far into an uncertain future that small changes in assumptions can swing the result enormously, so most early investors treat DCF as a sanity check at best.
The cost-to-duplicate approach asks a different question: how much would it cost to rebuild this company from scratch? It can set a rough floor, but it ignores brand, momentum, and the value of an idea that already works, so it typically understates a promising startup.
Revenue and ARR Multiples by Stage
Once you have revenue, valuation gets more concrete. Investors often price software companies as a multiple of annual recurring revenue, or ARR.
At the earliest stages, a revenue multiple is a rough guide at best. Many seed companies are priced more on team and trajectory than on any clean multiple, because revenue is small or just beginning. As of 2026, reported benchmarks vary widely by source and market conditions, with private software companies often falling somewhere in the low-to-mid single digits of ARR and faster growers commanding more.
Growth rate matters as much as the multiple itself. Companies growing faster than 40% year over year may command meaningfully higher multiples than peers growing under 20%, and AI-native businesses have recently shown stronger capital efficiency. Treat any single number as a starting point, and check current data for your sector before anchoring to it.
What Actually Drives Startup Valuation
Methods give you a range. What moves you within that range, or beyond it, comes down to a few human factors.
Team, traction, market size, and deal terms are the levers that move a startup valuation more than any formula. A credible founding team signals lower execution risk. Real traction, even modest revenue or strong usage, proves demand. A large and reachable market gives investors a reason to believe in a big outcome.
Terms matter too, and they are easy to overlook. A high headline valuation paired with heavy investor protections can leave a founder worse off than a lower number with clean terms.
How SAFEs and Valuation Caps Relate
Many early rounds skip a priced valuation entirely and use a SAFE, short for Simple Agreement for Future Equity. A SAFE lets an investor put money in now and convert it into shares later, usually at the next priced round.
The valuation cap is the key term. With a post-money SAFE, a $100,000 investment at a $10 million cap secures the investor at least 1% of the company before the next round, because the cap sets the maximum price at which their money converts.
We break this down further in our guide on the difference between pre-money and post-money valuation.
One detail trips up founders: the post-money cap is “post” all the SAFE money, but not post the later Series A. SAFE holders still get diluted by that priced round like everyone else, so stacking several SAFEs can quietly add up to more dilution than expected.
This is the kind of nuance that mentorship helps with. Founders in programs like Elev X!, the NEC X accelerator in Palo Alto, often work through cap tables and terms with experienced advisors before they sign anything.
Frequently Asked Questions
What is the best valuation method for a pre-revenue startup?
There is no single best method. Early founders often combine the Berkus and Scorecard methods, since both handle the absence of revenue, and then sanity-check the result against recent deals in their region and sector.
How do investors value a startup with no revenue?
They price risk and potential rather than financials. They weigh the team, the product, the market size, and any early signs of traction, frequently using comparison-based methods to anchor a defensible range.
What revenue multiple do startups get?
It depends heavily on stage, growth rate, and market conditions, and at the earliest stages a multiple is only a rough guide. As of 2026, private software companies have often fallen in the low-to-mid single digits of ARR, while fast-growing companies can command considerably more, so check current figures for your sector.
Does a valuation cap set my startup’s valuation?
Not exactly. A cap on a SAFE sets the maximum price at which that investment converts into equity later, which influences future dilution but is not the same as a priced valuation agreed in a formal round.
Sources
Waveup: Startup Valuation Methods Compared
Eqvista: Berkus Valuation Method for Startups
VirtueCPAs: Pre-Revenue Startup Valuation Methods Explained
SaaS Capital: Private SaaS Company Valuations
Y Combinator: Understanding SAFEs and Priced Equity Rounds
We do our best to ensure accuracy, but if you spot an error, please let us know at pr@nec-x.com.